A299170 Stock Overview
No business description
Price History & Performance
|Historical stock prices|
|Current Share Price||₩2,530.00|
|52 Week High||₩3,515.00|
|52 Week Low||₩2,285.00|
|1 Month Change||-8.50%|
|3 Month Change||3.69%|
|1 Year Change||-15.67%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-26.24%|
Recent News & Updates
|A299170||KR Healthcare||KR Market|
Return vs Industry: A299170 exceeded the KR Healthcare industry which returned -43.5% over the past year.
Return vs Market: A299170 matched the KR Market which returned -15.2% over the past year.
|A299170 Average Weekly Movement||3.5%|
|Healthcare Industry Average Movement||5.7%|
|Market Average Movement||5.6%|
|10% most volatile stocks in KR Market||10.4%|
|10% least volatile stocks in KR Market||3.2%|
Stable Share Price: A299170 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: A299170's weekly volatility (4%) has been stable over the past year.
About the Company
WSI Fundamentals Summary
|A299170 fundamental statistics|
Is A299170 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A299170 income statement (TTM)|
|Cost of Revenue||₩17.59b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||238.94|
|Net Profit Margin||25.83%|
How did A299170 perform over the long term?See historical performance and comparison
Is WSI undervalued compared to its fair value and its price relative to the market?
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: A299170 (₩2530) is trading below our estimate of fair value (₩17677.38)
Significantly Below Fair Value: A299170 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: A299170 is good value based on its PE Ratio (10.6x) compared to the Asian Healthcare industry average (18.1x).
PE vs Market: A299170 is good value based on its PE Ratio (10.6x) compared to the KR market (14.2x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate A299170's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A299170 is overvalued based on its PB Ratio (2.3x) compared to the KR Healthcare industry average (2.2x).
How is WSI forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as WSI has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has WSI performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Last years revenue growth
Earnings and Revenue History
Quality Earnings: A299170 has a high level of non-cash earnings.
Growing Profit Margin: A299170 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A299170's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: A299170 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A299170 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (34.8%).
Return on Equity
High ROE: A299170's Return on Equity (21.5%) is considered high.
How is WSI's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A299170's short term assets (₩47.6B) exceed its short term liabilities (₩18.0B).
Long Term Liabilities: A299170's short term assets (₩47.6B) exceed its long term liabilities (₩1.1B).
Debt to Equity History and Analysis
Debt Level: A299170 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A299170's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A299170's debt is well covered by operating cash flow (83.6%).
Interest Coverage: A299170's interest payments on its debt are well covered by EBIT (12.1x coverage).
What is WSI current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate A299170's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A299170's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if A299170's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A299170's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A299170 has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
WSI has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.7%.
WSI Co., Ltd.'s employee growth, exchange listings and data sources
- Name: WSI Co., Ltd.
- Ticker: A299170
- Exchange: KOSDAQ
- Founded: NaN
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: ₩75.971b
- Shares outstanding: 30.03m
- Website: https://wsi-healthcare.com
Number of Employees
- WSI Co., Ltd.
- 365 Hwarang-ro
- Bangchon-dong, Dong-gu
- South Korea
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/15 00:00|
|End of Day Share Price||2022/05/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.